| Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2 AG Khan, J Whidby, MT Miller, H Scarborough, AV Zatorski, A Cygan, ... Nature 509 (7500), 381-384, 2014 | 310 | 2014 |
| Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition M Casás-Selves, J Kim, Z Zhang, BA Helfrich, D Gao, CC Porter, ... Cancer research 72 (16), 4154-4164, 2012 | 151 | 2012 |
| Blocking hepatitis C virus infection with recombinant form of envelope protein 2 ectodomain J Whidby, G Mateu, H Scarborough, B Demeler, A Grakoui, ... Journal of virology 83 (21), 11078-11089, 2009 | 78 | 2009 |
| AZ1366: an inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non–small cell lung cancer cells following EGFR inhibition HA Scarborough, BA Helfrich, M Casás-Selves, AG Schuller, ... Clinical Cancer Research 23 (6), 1531-1541, 2017 | 53 | 2017 |
| Coupling an EML4-ALK–centric interactome with RNA interference identifies sensitizers to ALK inhibitors G Zhang, H Scarborough, J Kim, AI Rozhok, YA Chen, X Zhang, L Song, ... Science signaling 9 (450), rs12-rs12, 2016 | 34 | 2016 |
| Adenoviral vectors transduce alveolar macrophages in lung cancer models DD Tippimanchai, K Nolan, J Poczobutt, G Verzosa, H Li, H Scarborough, ... Oncoimmunology 7 (6), e1438105, 2018 | 18 | 2018 |
| Personalized one-two punches for lung cancer HA Scarborough, PA Bunn, J DeGregori Cell Research 25 (3), 269-270, 2015 | 5 | 2015 |
| Price 584 AA, Yost SA, Bohannon CD, Jacob J, Grakoui A, Marcotrigiano J AG Khan, J Whidby, MT Miller, H Scarborough, AV Zatorski, A Cygan | 2 | 2014 |
| Inflammation promotes aging-associated oncogenesis in the lung. C Pham-Danis, SB Chia, HA Scarborough, E Danis, T Nemkov, ... bioRxiv, 2024.03. 01.583044, 2024 | | 2024 |
| Abstract A026: Altered immune landscape in aging lungs contributes to malignant evolution SB Chia, C Pham-Danis, H Scarborough, N Little, EP Danis, ... Cancer Research 82 (10_Supplement), A026-A026, 2022 | | 2022 |
| Abstract IA012: Aging, tissue ecology, and the evolution of cancer within us J DeGregori, C Pham-Danis, AI Rozhok, EJ Evans, F Marongiu, ... Cancer Research 82 (10_Supplement), IA012-IA012, 2022 | | 2022 |
| Abstract IA13: In the light of evolution: Why do we get more cancers in old age? C Pham-Danis, A Rozhok, H Scarborough, N Little, C Henry, T Nemkov, ... Cancer Research 80 (21_Supplement), IA13-IA13, 2020 | | 2020 |
| Context-Dependent Oncogenic Adaptation in the Genesis of Lung Cancer H Scarborough, N Little, L Johnson, J DeGregori Journal of Thoracic Oncology 12 (8), S1545, 2017 | | 2017 |
| Determinants of Non-small Cell Lung Cancer Development and Resistance to Targeted Therapies HA Scarborough University of Colorado, 2017 | | 2017 |
| P3. 02b-084 Rational Combinations to Improve Outcome for EGFR-TKIs in NSCLCs with EGFR Mutations: Topic: EGFR Clinical B Helfrich, H Scarborough, L Heasley, K Ryall, AC Tan, J Degregori, ... Journal of Thoracic Oncology 12 (1), S1242, 2017 | | 2017 |
| Use of Pooled shRNA Synthetic Lethal Screens within an In Vivo Murine Model to Identify Microenvironment-Dependent Lung Cancer Genes NR Little, JM Poczobutt, HA Scarborough, H Li, R Nemenoff, JV Degregori JOURNAL OF THORACIC ONCOLOGY 10 (9), S470-S470, 2015 | | 2015 |
| Inhibiting Tankyrase Prevents Epithelial-To-Mesenchymal Transition and Synergizes with EGFR-Inhibition in Wnt-Dependent NSCLC Lines HA Scarborough, BA Helfrich, M Casas-Selves, Z Zhang, DC Chan, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S294-S294, 2015 | | 2015 |
| MAPPING AND CHARACTERIZING WNT PATHWAY DEPENDENCIES IN NON-SMALL CELL LUNG CANCER H Scarborough, M Casas-Selves, B Helfrich, J DeGregori JOURNAL OF INVESTIGATIVE MEDICINE 63 (1), 211-211, 2015 | | 2015 |
| Ltd. 1968. Pp. vi+ 687. Price£ 4. Professor Ellis died in 1966 within a year of the FRS FRIC, H SCARBOROUGH | | |
